In September, we shared that the Centers for Medicare and Medicaid Services (CMS) had proposed additional new CPT® codes for Remote Therapeutic Monitoring (RTM). These RTM codes had the potential to expand the coverage of remote monitoring in several important ways, including:
CMS released its final ruling on November 2, 2021 and our legal experts at Nixon Gwilt Law have evaluated the implications for healthcare organizations. While the new codes will enable practices to expand the conditions eligible for remote monitoring and the practitioners able to deliver those services, outstanding questions remain.
While the final RTM codes do not fully align with the services and structure of RPM, there are parallels as demonstrated in the chart below. The RPM codes are evaluation and management (E/M) services, whereas the RTM codes are general medicine codes, which allows a broader range of providers to order and bill for RTM. The examples that CMS cites for data that may be monitored through RTM include, “respiratory system status, musculoskeletal system status, therapy adherence, therapy response.”
RPM | RTM | |
Initial set-up and patient education on use of the equipment | CPT® code 99453 | CPT® code 98975 |
Device(s) supply with daily recording(s) or programmed alert transmission, each 30 days | CPT® code 99454 |
CPT® code 98976: Supply of Device for Monitoring Respiratory System CPT® code 98977: Supply of Device for Monitoring Musculoskeletal System |
Monitoring/Treatment Management Services, first 20 minutes | CPT® code 99457: clinical staff, QHCP, or physician time |
CPT® code 98980: physician/other qualified health care professional (QHCP) time or clinical staff under direct supervision of providers eligible for incident-to billing |
Monitoring/Treatment Management Services, each additional 20 minutes | CPT® code 99458: clinical staff, QHCP, or MD |
CPT® code 98981: physician/other qualified health care professional time or clinical staff under direct supervision of providers eligible for incident-to billing |
So, what does this all mean in terms of how practices can expand their remote monitoring programs?
While RTM opens many possibilities, “therapy adherence” is mentioned repeatedly in the 2022 Medicare Physician Fee Schedule Final Rule. With 125,000 deaths a year driven by medication nonadherence in the US, this could be one of the most promising opportunities to arise from the RTM codes. With adherence for chronic condition medications estimated to be only 50 percent, there is significant room for improvement. We’ve already seen how RPM can increase patient engagement and accountability through daily interactions with a care team member. Leveraging the built-in engagement tools of an RPM program with a smart-pill cap, such as Pillsy, has the potential to dramatically reduce the adverse outcomes of nonadherence.
CMS’ adoption of the new RTM codes is a clear indication that they believe remote monitoring is effective in driving positive clinical outcomes and reducing costs. The RTM codes open up multiple ways to increase the number of patients that can benefit from remote monitoring. However, in line with Nixon Gwilt’s guidance, we hope that CMS will further clarify and amend the RTM codes in the future. Allowing devices beyond respiratory and musculoskeletal and the use of clinical staff to conduct the monitoring under general supervision will enable more practical implementation.